Waiting times for prostate cancer: A review

被引:7
作者
Lazzeri, Giacomo [1 ,2 ]
Troiano, Gianmarco [1 ,3 ]
Porchia, Barbara Rita [2 ]
Centauri, Federica [2 ]
Mezzatesta, Vincenzo [2 ]
Presicce, Giorgio [2 ]
Matarrese, Daniela [4 ]
Gusinu, Roberto [5 ]
机构
[1] Univ Siena, Dept Mol & Dev Med, 2 Via A Moro, I-53100 Siena, Italy
[2] Azienda Osped Univ Senese, Hosp Direct, Siena, Italy
[3] Univ Siena, Siena, Italy
[4] Azienda USL Toscana Ctr, Hosp Network, Florence, Italy
[5] Azienda Osped Univ Senese, Siena, Italy
关键词
Prostate cancer; waiting time; review; DIAGNOSIS; DELAY;
D O I
10.4081/jphr.2020.1778
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Prostate cancer is one of the most common diagnosed cancers in men and the waiting time has become an important issue not only for clinical reasons, but also mostly for the psychological implications on patients. The aim of our study was to review and analyze the literature on waiting times for prostate cancer. In February-March 2019 we performed a search for original peer-reviewed papers in the electronic database PubMed (MEDLINE). The key search terms were "prostate cancer AND waiting list", "prostate cancer AND waiting times". We included in our narrative review articles in Italian, English or French, published in 2009-2019 containing original data about the waiting times for prostate cancer. The literature search yielded 680 publications. Finally, we identified 8 manuscripts eligible for the review. The articles were published between 2010 and 2019; the studies involved a minimum of 16 to a maximum of 95438 participants. Studies have been conducted in 6 countries. The waiting times from cancer suspicion to histopathological diagnosis and to treatment had an important reduction in the last years, and this constant decrease could lead to an increase of patients' satisfaction.
引用
收藏
页码:14 / 18
页数:5
相关论文
共 32 条
[1]   20-year outcomes following conservative management of clinically localized prostate cancer [J].
Albertsen, PC ;
Hanley, JA ;
Fine, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (17) :2095-2101
[2]  
Caldarelli G, 2017, ANN IG MED PREV COMU, V29, P218, DOI 10.7416/ai.2017.2149
[3]  
Campbell, 2020, WHAT IS QUAL CAR WHY
[4]   Prostate Cancer: Current Treatment and Prevention Strategies [J].
Chen, Fang-zhi ;
Zhao, Xiao-kun .
IRANIAN RED CRESCENT MEDICAL JOURNAL, 2013, 15 (04) :279-284
[5]  
Comber H, 2005, Ir Med J, V98, P238
[6]   Time Trends and Local Variation in Primary Treatment of Localized Prostate Cancer [J].
Cooperberg, Matthew R. ;
Broering, Jeanette M. ;
Carroll, Peter R. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (07) :1117-1123
[7]  
Danish Health and Medicines Authority, CANC PATHW
[8]  
Health & Social Care Information Centre NHS England, CANC WAIT TIM GUID V
[9]  
Huang Jin-An, 2004, J Chin Med Assoc, V67, P403
[10]  
InformedHealth.org, 2006, PROST CANC OV